Jay A. White
29Patents
9h-index
26Co-inventors
75Inventor score
Filing activity: Oct 1, 1996 → May 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6982258B2 | Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 | Human Necessities | 47 | Expired |
| US8207149B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 31 | Active |
| US8361488B2 | Methods and compositions for controlled release oral dosage of a vitamin D compound | Human Necessities | 29 | Active |
| US8778373B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 25 | Active |
| US7166585B2 | 24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3 | Chemistry; Metallurgy | 19 | Expired |
| US9408858B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 17 | Active |
| US9498486B1 | Method for controlled release oral dosage of a vitamin D compound | Human Necessities | 16 | Active |
| US10220047B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 14 | Active |
| US9861644B2 | Stabilized modified release vitamin D formulation and method of administering same | Human Necessities | 9 | Active |
| US9918940B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 8 | Active |
| US10350224B2 | Stabilized modified release vitamin D formulation and method of administering same | Human Necessities | 7 | Active |
| US10493084B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 7 | Active |
| US10357502B2 | Stabilized modified release vitamin D formulation and method of administering same | Human Necessities | 7 | Active |
| US10300078B2 | Stabilized modified release vitamin D formulation and method of administering same | Human Necessities | 6 | Active |
| US6063606A | Retinoid metabolizing protein | Chemistry; Metallurgy | 2 | Expired |
| US7115558B2 | P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8106035B2 | 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3 | Chemistry; Metallurgy | 1 | Expired |
| US6306624A | Retinoid metabolizing protein | Chemistry; Metallurgy | 1 | Expired |
| US11007205B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 1 | Active |
| US9925147B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 0 | Active |
| US11672809B2 | Methods and compositions for reducing parathyroid levels | Human Necessities | 0 | Active |
| US11154509B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 0 | Active |
| US11738033B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 0 | Active |
| US7335484B2 | Retinoid metabolizing protein | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6861238B1 | Retinoid metabolizing protein | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.